Search

A study conducted by a researcher at Kayseri University in Turkey focused on the effectiveness of non-pharmacological interventions such as physiotherapy, exercise, and relaxation techniques in managing acute migraines during pregnancy. The study involved sixty pregnant women diagnosed with acute migraines who were randomly assigned to different intervention groups. Results showed that all interventions significantly reduced migraine frequency, severity, and duration, with physiotherapy being the most effective in reducing frequency and severity, while exercise improved duration and relaxation techniques reduced stress and anxiety levels. The findings suggest that these non-invasive interventions can be safe and effective alternatives to pharmacological treatments for managing migraines during pregnancy, emphasizing the importance of holistic approaches to migraine management. [Extracted from the article]

A patent has been issued for speech analysis devices and methods developed by inventors from Arizona State University to identify migraine attacks. The technology aims to detect changes in speech patterns that may indicate the onset of a migraine, allowing for early intervention and treatment. By comparing speech features against baseline data, the devices can predict and identify migraine attacks, potentially reducing the severity and disability associated with migraines. The patent highlights the importance of early detection and treatment in improving outcomes for migraine sufferers. [Extracted from the article]

A study conducted by Eli Lilly and Company compared the healthcare resource utilization, costs, and treatment discontinuation of two migraine prevention medications, galcanezumab and rimegepant. The research found that patients who received galcanezumab had lower increases in medical and pharmacy costs compared to those who received rimegepant. Additionally, the treatment discontinuation rate was significantly lower in the galcanezumab cohort. This peer-reviewed study provides valuable insights into the effectiveness and cost implications of these migraine treatments. [Extracted from the article]

A study conducted by researchers at the University of Vermont examined the association between headache laterality in patients with migraine and the distribution of white matter hyperintensities on brain MRI. The study found that patients with typically left-sided headache during migraine attacks had a higher burden of white matter hyperintensities on both sides of the brain compared to patients with right-sided headache. This research sheds light on the potential relationship between headache laterality and brain abnormalities in migraine patients. [Extracted from the article]

A recent study conducted at the University of Health Sciences Turkiye focused on evaluating the sleep quality of adult patients presenting to the emergency department with migraine attacks. The research found that patients with migraine attacks had significantly higher sleep quality scores compared to healthy controls. The study highlighted the importance of assessing sleep quality in migraine patients for early prevention and treatment. For more information, readers can refer to the article "Evaluation of Sleep Quality in Patients with Migraine Attacks Presenting to the Emergency Department" published in Global Emergency and Critical Care. [Extracted from the article]

A recent study conducted by the Department of Neurology focused on understanding the interictal burden in migraine patients at the beginning of CGRP monoclonal antibody prevention. The research highlighted the importance of considering the holistic impact of interictal burden, which includes psychosocial and socioeconomic elements in addition to residual symptoms. The study emphasized the need to assess this additional burden when providing medical care to individuals with migraine. The findings suggest that factors such as income, well-being, anxiety sensitivity, and migraine pain can significantly influence the interictal burden experienced by migraine patients. [Extracted from the article]

Researchers from the Neurology Department have conducted a narrative review on the relationship between migraine and cognitive dysfunction. The study highlights the impact of cognitive impairment on the quality of life of migraine patients, emphasizing the need for further research in this area. While subjective reports suggest cognitive impairment in migraine patients, objective neuropsychological assessments show varying results, indicating the complexity of this relationship. Future studies should focus on longitudinal designs to assess cognition across different migraine phases and subtypes, while considering important confounders such as treatment use. [Extracted from the article]

Researchers from Kuwait University have developed a medical expert system called MDATES to diagnose and recommend treatment for migraines. The system, implemented using the CLIPS shell, showed high accuracy in diagnosing migraines based on 300 patient records. This research provides valuable assistance to medical professionals in diagnosing migraines and contributes to the broader context of rule-based expert systems for migraine diagnosis and treatment. The study was peer-reviewed and published in the Kuwait Journal of Science. [Extracted from the article]

Researchers at Polytechnic University Hospital la Fe conducted a study on the burden of episodic and chronic migraine in patients who had failed multiple preventive treatments in France, Spain, and the United Kingdom. The study found that migraine affects over 80 million people in Western Europe and evaluated disability and health-related quality of life among patients with episodic and chronic migraine. The research highlighted the substantial disability and decreased quality of life among patients who have failed previous preventive therapies, suggesting high unmet needs in all countries. The study concluded that appropriate treatment could reduce migraine-related burden and healthcare resource use among patients with difficult-to-treat migraine. [Extracted from the article]

Researchers from Mashhad University of Medical Sciences in Iran have conducted a study on personalized medicine in migraine therapy, focusing on nanoformulations. Nanoformulations, which combine nanoscale materials with therapeutic agents, show promise in enhancing drug delivery, increasing efficacy, and minimizing side effects for migraine treatment. The study highlights the potential of nanotechnology-based approaches to revolutionize migraine therapy by offering personalized and precise treatments, although challenges such as Blood-Brain Barrier penetration and regulatory approval remain. This research aims to improve patient outcomes and living standards by providing innovative solutions for migraine management. [Extracted from the article]

A recent study from the University of Copenhagen delves into the mechanisms of migraine without aura, contrasting it with migraine with aura. The research highlights the historical significance of studies on cerebral blood flow and vascular responses in understanding these conditions. The findings suggest a fundamental shift in our understanding of migraine, providing a solid foundation for further exploration in this field. For more information, the full article can be accessed in The Journal of Headache and Pain. [Extracted from the article]

Researchers from Leiden University Medical Center conducted a systematic review on pain profiling in migraine patients, focusing on Quantitative Sensory Testing (QST), Conditioned Pain Modulation (CPM), and Corneal Confocal Microscopy (CCM). The study found that migraine patients exhibit lower pressure pain thresholds (PPT) in the trigeminal region and may have a diminished CPM response with repeated executions. The research highlights the importance of understanding pain profiling in differentiating among migraine subtypes and offers insights into migraine pathophysiology. [Extracted from the article]

A recent study published in Neurology(R) suggests that a newly approved drug, atogepant, may start working immediately to prevent migraines. The drug, a calcitonin gene-related peptide (CGRP) receptor antagonist taken orally, was found to reduce the frequency of migraines in participants compared to a placebo. The study highlighted the need for effective and fast-acting migraine treatments, as migraines can significantly impact individuals' quality of life. However, it is important to note that the study primarily included female and white participants, so the results may not be generalizable to the entire population. [Extracted from the article]

Researchers at Nanchang University in Jiangxi, China, conducted a study on the risk factors of white matter lesions (WMLs) in patients with vestibular migraine (VM). The study found that the frequency of vertigo episodes was a significant independent risk factor for WMLs in VM patients. The results suggest that a high frequency of vertigo episodes may be associated with a higher risk of WMLs, providing insights for the prevention of WMLs in VM patients. The research was supported by the Science and Technology Program of the Jiangxi Provincial Health Commission and has been peer-reviewed. [Extracted from the article]

Research from Pontificia Universidade Catolica do Parana explores the relationship between food triggers and sensory hypersensitivity in patients with migraines. The study found that approximately 25% of individuals with migraines identify food as a trigger, with common triggers including alcohol, chocolate, and cheese. Patients with food triggers were more likely to experience symptoms like aura and photophobia, indicating a significant association between food triggers and sensory hypersensitivity in migraines. The presence of photophobia and osmophobia were identified as clinical predictors of food triggers in migraine patients. [Extracted from the article]

A recent study conducted by researchers at the University of Lodz in Poland explored the relationship between aging and migraine prevalence. The study found that migraine intensity tends to peak in one's 20s and 40s, after which headache attacks become less intense and occur less frequently. The researchers hypothesized that migraine affects individuals with genetic or acquired predispositions, which may be influenced by various aspects of aging such as social, cognitive, and metabolic factors. Further research is needed to explore the molecular mechanisms underlying social aging and its association with migraine predisposition and sex-based differences in prevalence. [Extracted from the article]

A recent study conducted at the University Rey Juan Carlos aimed to determine if clinical, psychological, or psychophysical variables could help differentiate women with migraines from those without. The study found that women with migraines exhibited lower pain thresholds compared to those without migraines, but none of the variables tested could accurately distinguish between women with and without migraines or between episodic and chronic migraines. The findings suggest that further research is needed to clarify the clinical relevance of these results. [Extracted from the article]

A study conducted by researchers at the University of Pecs in Hungary explored the association between internet use and the severity of primary headaches among Hungarian university students. The research found that spending more than 4 hours per day on the internet, experiencing mood disturbances, and insomnia were significant risk factors for the severity of primary headaches. While a slight correlation was identified between online activities and headache severity, further investigation is needed to fully understand this relationship. The study highlights the potential impact of internet use on tension-type headaches and calls for more research in this area. [Extracted from the article]

A recent study conducted in Padua, Italy, explored the effectiveness of the modified Atkins ketogenic diet (MAD) in treating drug-resistant migraine patients. The study found that after 6 and 12 months on the diet, patients experienced a significant decrease in the frequency, length, and intensity of migraine episodes, as well as a reduction in the number of medications needed. Additionally, metabolic markers such as body mass index and blood pressure also showed improvement. The research concluded that the ketogenic diet can be a safe and effective long-term treatment for drug-resistant migraines, although a high dropout rate remains a limiting factor. [Extracted from the article]

A recent study conducted at the University of Southern Denmark aimed to assess the migraine-inducing effects of sildenafil in men with migraine without aura. The trial will enroll 12 men and 15 women diagnosed with migraine without aura, with men participating in a randomized, placebo-controlled crossover trial. The primary endpoints include comparing the incidence of migraine attacks in sildenafil-treated men to placebo and between men and women, with secondary endpoints focusing on headache incidence, heart rate, mean arterial pressure, and adverse events. The findings of this research may contribute to a better understanding of sex-related differences in migraine mechanisms and potentially lead to more tailored treatment approaches. [Extracted from the article]

Researchers from the Second Affiliated Hospital of Qiqihar Medical University in China conducted a study to evaluate the effectiveness of duloxetine in treating vestibular migraine. The study included 72 patients and found that duloxetine treatment significantly reduced vestibular symptoms compared to other medications, with fewer adverse reactions. The research contributes to the growing evidence supporting the use of duloxetine for vestibular migraine treatment. [Extracted from the article]

A recent study conducted at Xiangyang No. 1 People's Hospital explored the relationship between 25-hydroxyvitamin D levels and severe headaches or migraines. The research, based on data from the NHANES database, found a significant negative correlation between serum 25(OH)D levels and the risk of severe headaches or migraines. The study suggested that further clinical research is needed to confirm these findings and explore potential preventive and therapeutic mechanisms for migraines, particularly in females, non-smokers, and non-hypertensive individuals. [Extracted from the article]

A study conducted at Bambino Gesu Children's Hospital in Rome, Italy, focused on coping strategies for adolescents with migraine in response to stressful events. The research found that adolescents with more severe migraine patterns tended to use maladaptive coping strategies, leading to higher levels of anxiety and depression. The study highlighted the importance of understanding how adolescents with migraines cope with stress and the impact it has on their mental health. For more information, the research can be found in The Journal of Headache and Pain. [Extracted from the article]

The article discusses a post-marketing study on the long-term safety, utilization, and efficacy of the Nerivio device, a Remote Electrical Neurostimulation (REN) device for patients with migraines. The study aims to assess adverse events, monthly treatments, and changes in headache pain severity and functional disability over a 3-year period. The device, approved by the FDA, delivers transcutaneous electrical stimulation to the upper arm to treat migraines and is controlled by a smartphone application. The study is observational in nature and aims to recruit 300 participants for a 3-year follow-up period. [Extracted from the article]

A study conducted by Universidad Simon Bolivar in Barranquilla, Colombia, focused on a rare variant of migraine called Ophthalmoplegic Migraine (OM) in a pregnant woman. The 34-year-old woman experienced severe headaches, nausea, vomiting, and other symptoms during her pregnancy, with limited improvement despite various treatments. The researchers highlighted the complexity of OM, especially during pregnancy, and suggested a potential link to hormonal and physiological changes. The study emphasized the need for a multidisciplinary approach to managing this rare condition. [Extracted from the article]

Researchers at the University of Alabama Birmingham conducted a study on the association between white matter hyperintensities and migraine-like headache in United States military veterans with mild traumatic brain injury. The study included 83 veterans, mostly males, with a median age of 36 years. The findings suggest that there is no significant association between the prevalence of white matter hyperintensities and the presence or severity of migraine-like headache in veterans with a history of mild traumatic brain injury. [Extracted from the article]

Researchers at H. Lundbeck AS in Valby, Denmark, have published a report on migraine, a neurological disorder affecting millions globally. The study discusses the potential use of one-photon miniscopes for imaging in freely moving animals to gain insights into migraine pathophysiology. The research aims to drive the development of novel therapeutic strategies for effective migraine management. This peer-reviewed study can be found in Synapse, and more information can be obtained from the authors at H. Lundbeck AS. [Extracted from the article]

A systematic review conducted by the University of California San Francisco (UCSF) analyzed randomized clinical trials testing changes in daily water intake and their impact on health outcomes. The review found that increasing water consumption was associated with greater weight loss and fewer nephrolithiasis events. Some studies also suggested potential benefits for migraine prevention, urinary tract infection, diabetes control, and hypotension. The researchers recommended further well-designed studies to assess the benefits of increased water intake in specific conditions. [Extracted from the article]

Researchers from the University of Florence conducted a study on patients who discontinued treatment with anti-CGRP monoclonal antibodies for migraine. The study found that about 25% of patients failed to respond to the treatment, leading to discontinuation. The majority of patients discontinued due to ineffectiveness, with 77.9% ceasing treatment within the first year. Further research is needed to identify non-responder features and address unmet needs in migraine treatment. [Extracted from the article]

Theranica, a neuromodulation therapeutics company, achieved significant milestones in 2024, including an expanded age indication from the FDA for their Nerivio REN wearable, allowing treatment for patients aged eight and older. A study published in Children highlighted the challenges children face in treating migraines at school, with the REN wearable offering a discreet and effective first-line treatment option. The FDA clearance for the REN wearable in children addresses the limitations of pharmacological treatments, providing a safe and effective alternative for early intervention and improving overall quality of life. Theranica also saw one million treatments with broader insurance coverage, making the non-drug migraine treatment accessible to 30 million Americans. [Extracted from the article]

A recent study conducted by researchers at Sapienza University of Rome focused on the local dynamic stability of the trunk during gait in individuals with episodic migraine. The study found that subjects with migraine without aura exhibited higher values of largest Lyapunov's exponent for a short time series (sLLE) and reduced pelvic rotation, pelvic tilt, and stride length values compared to healthy subjects. These findings suggest that sLLE may serve as a potential measure of dynamic instability in individuals with episodic migraine. The study provides new insights into postural balance control mechanisms in this population. [Extracted from the article]

A study conducted by researchers at Sapienza University of Rome focused on the neurophysiological effects of withdrawal from acute overused medications in patients with chronic migraine and medication-overuse headache. The study found that withdrawal from overused drugs could reduce the increased excitability of the non-painful somatosensory system in these patients, leading to a decrease in sensitization at both thalamocortical and cortical levels. The findings suggest that medication withdrawal may have a positive impact on neurophysiological abnormalities associated with chronic migraine and medication-overuse headache. [Extracted from the article]

A recent study funded by Pfizer examined the burden and healthcare resource utilization among individuals with migraine in Europe. The research found that individuals with migraine, even those experiencing only one migraine headache day, reported lower quality of life, higher depression, decreased productivity, and increased healthcare resource utilization compared to those without migraine. The study highlights the importance of effective management strategies for migraine sufferers. The full article can be accessed for free through the publisher's website. [Extracted from the article]

A study conducted by Mayo Clinic explored the impact of photophobia, or sensitivity to light, on work productivity and migraine-related disability among individuals with migraines. The research, funded by the American Migraine Foundation, found that severe photophobia was associated with reduced work productivity, higher presenteeism, absenteeism, activity impairment, and migraine-related disability. The study included over a thousand participants and utilized various questionnaires to assess the relationships between photophobia severity and these outcomes. The findings suggest that addressing photophobia may be crucial in managing migraines and improving overall quality of life for individuals affected by this condition. [Extracted from the article]

Recent research from Emory University highlights the prevalence and impact of migraine disease, affecting one in seven Americans. The study discusses the emergence of novel therapies targeting the calcitonin-gene-related-peptide pathway for migraine treatment, which have shown efficacy in reducing the burden of the disease. The research emphasizes the importance of introducing these new therapies to improve the quality of life for patients suffering from migraine, addressing concerns about adverse effects from standard preventive treatments. [Extracted from the article]

A recent report from the Medical University of Lublin discusses menstrual migraines, which are migraines that occur in alignment with the menstrual cycle and affect women of various age groups. These migraines can be more resistant to standard treatments, highlighting the need for specialized management approaches. Triptans are commonly used for acute menstrual migraine episodes, with newer medications like lasmiditan showing promise. Additionally, monoclonal antibodies targeting the CGRP receptor have demonstrated efficacy in short-term prevention. The research emphasizes the importance of raising awareness and recognition of menstrual migraines for more effective treatment. [Extracted from the article]

The article "The Role of Curcumin Supplementation in Patients with Migraine: A Meta-Analysis of Randomized Controlled Trial" explores the potential benefits of curcumin, a compound found in turmeric, in alleviating migraine symptoms. The meta-analysis of four studies involving 170 patients suggests that curcumin supplementation may reduce the severity of headache symptoms in individuals with migraines. However, it is important to note that this research has not yet undergone peer review. [Extracted from the article]

A recent study from the Service of Neurology highlights the connection between recurrent syncope and migraine attacks. The research suggests that loss of consciousness during migraine attacks may be due to autonomic impairment rather than just pain reflexes. A case study of a 51-year-old woman experiencing syncope after vomiting during migraines revealed cardiac conduction abnormalities, emphasizing the importance of investigating syncope during migraine episodes to avoid misdiagnosis. This study underscores the need for clinical suspicion and proper evaluation of syncope in migraine patients to ensure accurate treatment. [Extracted from the article]

A recent study conducted at Baqiyatallah University of Medical Sciences in Tehran, Iran, examined the association between migraine headaches and cerebrovascular accidents (CVAs) with variations in the Circle of Willis (CoW) arterial structure. The study found that anatomical variations in the posterior portions of the CoW were linked to both migraine and CVA patients. Further research is needed to determine the prevalence and significance of these variations. For more information, readers can access the full article in Advanced Biomedical Research. [Extracted from the article]

A recent study conducted in Peru found that nearly two-thirds of adults in the country suffer from active headache disorders. The research, funded by Ntnu Norwegian University of Science And Technology, assessed the burden of headache disorders at both individual and population levels. The study highlighted the significant impact of headache disorders on health and productivity in Peru, emphasizing the need for healthcare interventions to address these issues. For more information, the full article can be accessed in The Journal of Headache and Pain. [Extracted from the article]

Researchers from Nagoya University Graduate School of Medicine conducted a study on the real-world clinical results of anti-calcitonin gene-related peptide monoclonal antibody (CGRP-mAb) treatment for medication overuse headache (MOH) in patients with migraine. The study included 33 patients with migraine and MOH, and after the third CGRP-mAb injection, there was a significant decrease in monthly headache days, monthly migraine days, and monthly acute medication use. The research concluded that CGRP-mAb treatment reduced the frequency of headache symptoms and acute medication use without abrupt drug discontinuation or hospitalization. [Extracted from the article]

A study conducted at Washington University in St. Louis, United States, explored the relationship between migraine and persistent positive dysphotopsia following monofocal lens implantation. The research involved 385 participants, with 66 experiencing persistent dysphotopsia, and found that migraine prevalence was higher among those with dysphotopsia. The study suggested that a history of migraine may increase dysphotopsia severity and decrease patient satisfaction, highlighting the importance of considering individual factors in lens choice to improve outcomes. [Extracted from the article]

A study conducted by the University of L'Aquila in Italy examined the differences in comorbidities among individuals with resistant and refractory migraine compared to those with non-resistant and non-refractory migraine. The research found that individuals with resistant and refractory migraine had a higher burden of psychiatric comorbidities, trigger points, temporomandibular joint disorders, thyroiditis, and cerebrovascular diseases. The study suggests that proper treatment of these comorbidities may help overcome treatment resistance or refractoriness in migraine patients. Longitudinal studies are recommended to further understand the association between comorbidities and resistant or refractory migraine. [Extracted from the article]

Researchers from Zhejiang University have published a study on the prodrome of migraine, focusing on the early warning signs and potential therapeutic strategies for this chronic neurovascular disease. The prodrome stage of migraine has been increasingly recognized as a crucial window for intervention and treatment. The study delves into the pathophysiological and molecular mechanisms of the prodromal stage, offering insights into novel approaches for preventing or mitigating migraine onset. For more information, readers can access the full article in Frontiers in Neurology. [Extracted from the article]

ShiraTronics has initiated a pivotal study for its implantable neuromodulation therapy for Chronic Migraine, aiming to provide preventive relief for individuals with frequent headaches. The study will assess the safety and efficacy of the therapy in up to 148 patients in the United States and Australia. With a focus on long-term solutions for Chronic Migraine, the ShiraTronics System targets nerve pathways to potentially reduce the frequency and intensity of migraine attacks, offering a non-pharmacologic option for those seeking relief. [Extracted from the article]

A recent study from the University of Physical Education in Krakow evaluated the effectiveness of spinal manipulations as a treatment for migraine headaches. The research, which included six randomized clinical trials with 645 participants, found that spinal manipulation therapy had no significant effect on migraine intensity, duration, or emotional quality of life. Additionally, the study indicated that spinal manipulations increased the risk of adverse events. The researchers concluded that the effectiveness of spinal manipulations for treating migraines remains unproven, and called for larger, more rigorous studies to address existing uncertainties. [Extracted from the article]

A recent study conducted at MedStar Georgetown University Hospital evaluated the safety and tolerability of using ubrogepant for acute migraine treatment in participants already taking atogepant for preventive treatment. The study, funded by AbbVie, found that the concomitant use of ubrogepant and atogepant was safe and well-tolerated, with no new safety concerns identified. The research, published in Headache The Journal of Head and Face Pain, concluded that the overall safety profiles of atogepant and ubrogepant remained consistent when used together. [Extracted from the article]

A recent study conducted at Taif University in Saudi Arabia explored the prevalence of migraines among individuals with nasal obstruction. The research found a high incidence of migraines among participants with nasal obstruction, highlighting the impact of this health issue on individuals' quality of life. The study emphasizes the need for improved diagnosis, management, and quality of life for those affected by nasal obstruction and migraines. [Extracted from the article]

A recent report from the University of British Columbia discusses research findings on migraine, focusing on the impact of the pathogenic familial hemiplegic migraine type 1 S218L mutation on Cav2.1 P/Q-type calcium channels. The study explores how alternative splicing of Cav2.1 pre-mRNA generates diverse channel isoforms with distinct properties, affecting channel function under pathological conditions. The research highlights the differential impact of the S218L mutation on the molecular structure and electrophysiological properties of Cav2.1 isoforms, shedding light on potential implications for inherited neurological disorders. [Extracted from the article]

A recent study conducted by researchers at Ain Shams University compared the efficacy of ultrasound-guided sphenopalatine ganglion block and greater occipital nerve block in managing chronic migraines. The study, which included 40 patients, found that both treatments led to significant improvements, with the sphenopalatine ganglion block showing better results. The researchers concluded that nerve blocks, particularly the sphenopalatine ganglion block, could be effective in treating chronic resistant migraines, suggesting the need for further research with a larger patient population to confirm these findings. [Extracted from the article]